Your browser doesn't support javascript.
loading
A Practical Guide to Curing Onychomycosis: How to Maximize Cure at the Patient, Organism, Treatment, and Environmental Level.
Gupta, Aditya K; Versteeg, Sarah G; Shear, Neil H; Piguet, Vincent; Tosti, Antonella; Piraccini, Bianca Maria.
Afiliação
  • Gupta AK; Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada. agupta@mediproberesearch.com.
  • Versteeg SG; Mediprobe Research Inc., 645 Windermere Road, London, ON, N5X2P1, Canada. agupta@mediproberesearch.com.
  • Shear NH; Mediprobe Research Inc., 645 Windermere Road, London, ON, N5X2P1, Canada.
  • Piguet V; Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada.
  • Tosti A; Division of Dermatology, Department of Medicine, University of Toronto School of Medicine, Toronto, ON, Canada.
  • Piraccini BM; Division of Dermatology, Women's College Hospital, Toronto, ON, Canada.
Am J Clin Dermatol ; 20(1): 123-133, 2019 Feb.
Article em En | MEDLINE | ID: mdl-30456537
ABSTRACT
Onychomycosis is a fungal nail infection caused by dermatophytes, non-dermatophyte molds, and yeasts. Treatment of this infection can be difficult, with relapse likely to occur within 2.5 years of cure. The objective of this article is to review factors that can impact cure and to suggest practical techniques that physicians can use to maximize cure rates. Co-morbidities, as well as disease severity and duration, are among the many patient factors that could influence the efficacy of antifungal therapies. Furthermore, organism, treatment, and environmental factors that may hinder cure include point mutations, biofilms, affinity for non-target enzymes, and exposure to fungal reservoirs. To address patient-related factors, physicians are encouraged to conduct confirmatory testing and treat co-morbidities such as tinea pedis early and completely. To combat organism-focused factors, it is recommended that disruption of biofilms is considered, and drugs with multiple routes of delivery and unique mechanisms of action are prescribed when traditional agents are not effective. Extending follow-up periods, using combination treatments, and considering pulse regimens may also be of benefit. Through these practical techniques, physicians can maximize cure and limit the risk of relapse and re-infection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Onicomicose / Dermatologia / Dermatoses do Pé / Dermatoses da Mão / Antifúngicos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Am J Clin Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Onicomicose / Dermatologia / Dermatoses do Pé / Dermatoses da Mão / Antifúngicos Tipo de estudo: Diagnostic_studies / Guideline Limite: Humans Idioma: En Revista: Am J Clin Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá